@MHRAgovuk If traditional pathways weren’t designed for advanced personalised therapies, then why has DCVax-L remained under review for nearly 29 months with no public clarity? Glioblastoma patients don’t have time for endless silence. $NWBO #DCVaxL
If traditional pathways weren’t designed for advanced personalised therapies, then why has DCVax-L remained under review for nearly 29 months with no public clarity? Glioblastoma patients don’t have time for endless silence. $NWBO #DCVaxL
Traditional development pathways weren't designed for many rare diseases.
We're consulting on a new framework that could support earlier access to promising therapies while maintaining patient safety.
Have your say before 30 July 2026
- 🔗 https://t.co/5RkQqWqYmq
29 months. No rejection. No withdrawal. No transparency. Glioblastoma patients are still waiting while DCVax-L remains under MHRA review. At some point silence stops looking cautious and starts looking unacceptable. @MHRAgovuk $NWBO
29 months post-MHRA submission. No rejection. No withdrawal. No transparency. Today $NWBO flushed below $0.19 before reclaiming $0.20 into close. The market is frustrated, exhausted and still waiting for answers. At some point this process has to conclude.
You asked to hear from patients and families. They have been waiting 27+ months on the $NWBO #DCVax MAA. #Glioblastoma is a rare cancer. Median survival is 14 months. A new way forward starts with the application already on your desk.
Fewer than 5% of rare diseases have an approved treatment. The average diagnosis takes over five years. We're proposing a new way forward, and we want to hear from patients, families and carers like you.
Open to all, respond before 30th July 2026 – https://t.co/VFRcsEVNoS
MHRA now openly discussing modernising regulation for advanced personalised therapies while DCVax-L sits nearly 29 months into review with no rejection or withdrawal. Says a lot about how difficult these next-gen treatments are to regulate. $NWBO
$NWBO Interesting new court ruling. Judge rejected Citadel’s argument and confirmed NWBO’s spoofing claims already survived before Professor Mitts’ analyses were added. Not a final win, but definitely another procedural victory for NWBO in the market manipulation case. 👀
Hi 👋 Rebecca,
My name is Thomas O.,I was administered the DCVax @UCLA by Dr. Linda Liau in March of 2015. I just donated to your GOFUNDMe. This may sixth I celebrated my 50th birthday. It’s been 11 years since my diagnosis. 11 years to watch my son grow up; he was 3 & a half months old when I had a Gran Mal seizure in my kitchen. I wanted to let you know I feel nurses are the unsung heroes of the hospital. They are the ones keeping you comfortable in times when you can’t communicate. They were many hats & even mind reader in some situations.
I hope my donation helps, but more importantly I hope you read this tweet. Greedy people are against this scientific breakthrough in personalized immunotherapy.
I guess they’re in the U.K as well. Shame on anyone who puts profits over people.
They’ll have there day…
I won’t stop until they do.
Sincerely,
Thomas O.
@LisainNJUSA@kshaughnessy2@HollensbeAmanda@NHSNW@NorthwestBio@NYMag@ElvirPons@JackAWynn@TheLastWord@LastWeekTonight
$NWBO Glioblastoma patients have waited long enough. If the hold-up is manufacturing, data review, or process complexity — fine. But transparency matters. Silence only creates more uncertainty for patients and investors alike. @MHRAgovuk#NWBO#DCVax
$NWBO
Former Firefighter Given Months to Live Turns to DCVax -
With a Song Soaring on the @iTunes Charts to Save Him
@GrampianOnline reports James McPherson, a 46-year-old former firefighter from Moray, Scotland, was diagnosed with glioblastoma in February and given 12-15 months to live.
A charity remix of a local festival song shot to No.3 on the iTunes charts.
All the money is going toward the DCVax - L vaccine which trains the body to attack the cancer cells.
“I know this is going to kill me,” says James. “But with the vaccine I could have another 20 years. I’d settle for that right now.”
Courtesy @yachtmastter
$NWBO Thousands of glioblastoma patients have waited years for new treatment options. DCVax-L has generated global attention, yet patients are still waiting for clarity. Transparency and timely decisions matter when lives are involved. @MHRAgovuk#NWBO#DCVax#Glioblastoma